CYTOKINETICS, INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.11 USD | +0.38% |
|
-9.47% | -29.21% |
| 09/05 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
| 08/05 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |